Table 4. Hazards ratio (HR) of respiratory tract carcinomas in relation to combined levels of cigarette smoking status, and frequency of incense use, Singapore Chinese Health Study 1993-2005.
| Level of incense use | ||||
|---|---|---|---|---|
| Non-current users† | Low
(night/intermittent) |
High
(day/all times) |
P for trend | |
| Upper respiratory tract Nasopharyngeal carcinoma | ||||
| Never smokers | ||||
| No. cases | 30 | 57 | 14 | |
| HR (95% CI)* | 1.0 (referent) | 0.7 (0.5-1.2) | 1.0 (0.5-2.0) | 0.49 |
| Ever smokers | ||||
| No. cases | 10 | 55 | 9 | |
| HR (95% CI)* | 1.0 (referent) | 1.4 (0.7-2.7) | 1.4 (0.6-3.5) | 0.38 |
| Upper respiratory tract Non-nasopharyngeal carcinoma | ||||
| Never smokers | ||||
| No. cases | 5 | 25 | 7 | |
| HR (95% CI)* | 1.0 (referent) | 2.2 (0.8-5.9) | 3.3 (1.0-10.7) | 0.04 |
| Ever smokers | ||||
| No. cases | 14 | 82 | 17 | |
| HR (95% CI)* | 1.0 (referent) | 1.3 (0.7-2.4) | 1.7 (0.8-3.5) | 0.16 |
| Lung cancer | ||||
| Never smokers | ||||
| No. cases | 69 | 140 | 23 | |
| HR (95% CI)* | 1.0 (referent) | 0.8 (0.6-1.1) | 0.7 (0.4-1.1) | 0.09 |
| Ever smokers | ||||
| No. cases | 90 | 429 | 70 | |
| HR (95% CI)* | 1.0 (referent) | 1.1 (0.8-1.3) | 1.0 (0.7-1.4) | 0.88 |
Adjusted for age at recruitment, year of interview, gender, dialect group, level of education, body mass index, number of cigarettes/day, number of years of smoking, time since smoking cessation, alcohol consumption, dietary intakes of isothiocyanate, beta-cryptoxanthin, lutein, lycopene and summed Chinese preserved foods, and for women, number of children (see details in the Materials and Methods).
Including both never and former users of incense.